Vanguard Personalized Indexing Management
TGTX icon

Vanguard Personalized Indexing Management’s TG Therapeutics TGTX Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$980K Buy
17,832
+3,679
+26% +$151K 0.01% 1008
2026
Q1 		$470K Buy
14,153
+4,557
+47% +$136K ﹤0.01% 1348
2025
Q4 		$286K Sell
9,596
-210
-2% -$6.86K ﹤0.01% 1549
2025
Q3 		$354K Sell
9,806
-286
-3% -$9.42K ﹤0.01% 1412
2025
Q2 		$363K Buy
10,092
+17
+0.2% +$633 ﹤0.01% 1358
2025
Q1 		$397K Buy
10,075
+1,208
+14% +$40.6K 0.01% 1218
2024
Q4 		$267K Buy
+8,867
New +$254K ﹤0.01% 1390
2021
Q4 		– Sell
-10,730
Closed -$357K – 1110
2021
Q3 		$357K Buy
+10,730
New +$332K 0.03% 692

Other funds holding TGTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Vanguard Personalized Indexing Management's TGTX Position: Q2 2026 in Review

Vanguard Personalized Indexing Management increased its TG Therapeutics (TGTX) stake by 26% in Q2 2026, buying an estimated $151K and bringing the position to 17,832 shares worth $980K. The position accounts for 0.01% of the portfolio, ranked #1008.

Vanguard Personalized Indexing Management first reported a position in TGTX in Q3 2021 and has held it in 8 quarters since. 427 funds tracked by Wall St. Rank hold TGTX as of Q2 2026.

  • Vanguard Personalized Indexing Management held 17,832 shares of TG Therapeutics worth $980K as of Q2 2026.
  • Vanguard Personalized Indexing Management bought 3,679 TG Therapeutics shares in Q2 2026, an estimated $151K.
  • TG Therapeutics made up 0.01% of Vanguard Personalized Indexing Management's portfolio in Q2 2026, its #1008 holding.
  • Vanguard Personalized Indexing Management first reported a position in TG Therapeutics in Q3 2021 and has held it in 8 quarters since.
  • 427 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2026.

Based on Vanguard Personalized Indexing Management's 13F filing for Q2 2026, filed 11 Aug 2026.